 |
PDBsum entry 4x9p
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Calcium binding protein
|
PDB id
|
|
|
|
4x9p
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Calcium binding protein
|
 |
|
Title:
|
 |
Crystal structure of bovine annexin a2
|
|
Structure:
|
 |
Annexin a2. Chain: a. Synonym: annexin ii,annexin-2,calpactin i heavy chain,calpactin-1 heavy chain,chromobindin-8,lipocortin ii,placental anticoagulant protein iv,pap-iv,protein i,p36. Engineered: yes
|
|
Source:
|
 |
Bos taurus. Bovine. Organism_taxid: 9913. Gene: anxa2, anx2. Expressed in: escherichia coli. Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
2.01Å
|
R-factor:
|
0.159
|
R-free:
|
0.209
|
|
|
Authors:
|
 |
I.A.Shumilin,H.Hollas,A.Vedeler,R.H.Kretsinger
|
|
Key ref:
|
 |
A.M.Raddum
et al.
(2015).
The native structure of annexin A2 peptides in hydrophilic environment determines their anti-angiogenic effects.
Biochem Pharmacol,
95,
1.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-Dec-14
|
Release date:
|
14-Jan-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P04272
(ANXA2_BOVIN) -
Annexin A2 from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
339 a.a.
314 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochem Pharmacol
95:1
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
The native structure of annexin A2 peptides in hydrophilic environment determines their anti-angiogenic effects.
|
|
A.M.Raddum,
H.Hollås,
I.A.Shumilin,
P.Henklein,
R.Kretsinger,
T.Fossen,
A.Vedeler.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The progression of aggressive cancer occurs via angiogenesis and metastasis
makes these processes important targets for the development of anti-cancer
agents. However, recent studies have raised the concern that selective
inhibition of angiogenesis results in a switch towards increased tumour growth
and metastasis. Since Annexin A2 (AnxA2) is involved in both angiogenesis and
metastasis, it may serve as an ideal target for the simultaneous inhibition of
both processes. Based on the discovery that domains I (DI) and IV (DIV) of AnxA2
are potent inhibitors of angiogenesis, we designed seven peptides derived from
these domains based on AnxA2 crystal structures. The peptides were expressed as
fusion peptides to increase their folding and solubility. Light scattering,
far-UV circular dichroism and thermal transition analyses were employed to
investigate their aggregation tendencies, α-helical propensity and stability,
respectively. 2,2,2-trifluoroethanol (50%) increased the α-helical propensities
of all peptides, indicating that they may favour a hydrophobic environment, but
did not enhance their thermal stability. DI-P2 appears to be the most stable and
folded peptide in a hydrophilic environment. The secondary structure of DI-P2
was confirmed by nuclear magnetic resonance spectra. The effect of the seven
AnxA2 peptides on the formation and integrity of capillary-like networks was
studied in a co-culture system mimicking many of the angiogenesis-related
processes. Notably, DI-P2 inhibited significantly network formation in this
system, indicating that the folded DI-P2 peptide interferes with vascular
endothelial growth factor-dependent pro-angiogenic processes. Thus, this peptide
has the potential of being developed further as an anti-angiogenic drug.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |